CLDX
Celldex Therapeutics Inc
NASDAQ: CLDX · HEALTHCARE · BIOTECHNOLOGY
$32.14
-3.28% today
Updated 2026-04-29
Market cap
$2.52B
P/E ratio
—
P/S ratio
1,632.24x
EPS (TTM)
$-3.90
Dividend yield
—
52W range
$18 – $36
Volume
1.1M
Celldex Therapeutics Inc (CLDX) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.93M | $5.10M | $7.46M | $15.18M | $46.79M | $9.27M | $11.20M | $4.11M | $3.59M | $5.48M | $6.79M | $12.74M | $9.54M | $3.57M | $7.42M | $4.65M | $2.36M | $6.88M | $7.02M | $1.50M |
| Revenue growth (YoY) | — | +3.5% | +46.1% | +103.6% | +208.3% | -80.2% | +20.9% | -63.3% | -12.8% | +52.8% | +23.8% | +87.8% | -25.2% | -62.5% | +107.6% | -37.3% | -49.3% | +192.0% | +2.0% | -78.6% |
| Cost of revenue | $17.64M | $24.51M | $38.92M | $8.40M | $12.08M | $9.12M | $10.78M | $2.33M | $3.40M | $4.01M | $102.03M | $96.17M | $66.45M | $42.67M | $42.53M | $53.31M | $82.26M | $118.01M | $163.55M | — |
| Gross profit | $4.93M | $5.10M | $7.46M | $6.78M | $34.72M | $146000.00 | $427000.00 | $1.78M | $185000.00 | $1.47M | $-95.24M | $-83.43M | $-56.91M | $-39.10M | $-35.12M | $-48.66M | $-79.90M | $-111.13M | $-156.53M | $1.50M |
| Gross margin | 100.0% | 100.0% | 100.0% | 44.7% | 74.2% | 1.6% | 3.8% | 43.2% | 5.2% | 26.8% | -1403.5% | -654.7% | -596.7% | -1094.3% | -473.4% | -1046.2% | -3389.9% | -1614.5% | -2229.8% | 100.0% |
| R&D | $18.07M | $18.50M | $26.35M | $26.17M | $27.65M | $32.44M | $47.40M | $67.40M | $104.38M | $100.17M | $102.73M | $96.17M | $66.45M | $42.67M | $40.53M | $56.81M | $82.26M | $118.01M | $163.55M | $245.10M |
| SG&A | $8.24B | $8.50B | $14.75B | $17.12M | $10.43M | $9.24M | $10.02M | $14.80M | $20.62M | $33.84M | $35.98M | $25.00M | $19.27M | $15.43M | $14.46M | $20.49M | $27.20M | $30.91M | $38.55M | $43.80M |
| Operating income | $-22.37M | $-22.85M | $-34.00M | $-32.85M | $-6.46M | $-43.40M | $-58.08M | $-81.44M | $-122.43M | $-129.54M | $-132.92M | $-121.53M | $-156.44M | $-55.03M | $-63.35M | $-71.24M | $-115.23M | $-154.54M | $-195.08M | $-287.40M |
| Operating margin | -453.6% | -447.9% | -456.0% | -216.4% | -13.8% | -468.4% | -518.5% | -1981.1% | -3414.1% | -2363.9% | -1958.7% | -953.7% | -1640.1% | -1540.2% | -854.1% | -1531.8% | -4889.0% | -2245.3% | -2778.9% | -19160.0% |
| EBITDA | $-18.16M | $-19.07M | $-44.96M | $-33.07M | $4.67M | $-38.84M | $-54.41M | $-77.68M | $-114.68M | $-125.53M | $-124.44M | $-104.02M | $-72.60M | $-49.67M | $-45.64M | $-66.08M | $-104.20M | $-139.03M | $-191.90M | $-255.42M |
| EBITDA margin | -368.2% | -373.7% | -603.1% | -217.9% | 10.0% | -419.2% | -485.7% | -1889.5% | -3198.0% | -2290.7% | -1833.7% | -816.3% | -761.2% | -1390.1% | -615.3% | -1420.8% | -4420.9% | -2020.0% | -2733.6% | -17028.0% |
| EBIT | $-20.25M | $-21.76M | $-47.50M | $-36.60M | $-1.20M | $-43.00M | $-57.55M | $-80.62M | $-118.08M | $-129.54M | $-128.53M | $-109.33M | $-76.40M | $-54.52M | $-49.57M | $-69.15M | $-107.10M | $-142.04M | $-195.08M | $-258.80M |
| Interest expense | $4.23M | $2.19M | $156000.00 | $452000.00 | $1.34M | $1.80M | $1.58M | $927000.00 | $0.00 | $0.00 | $0.00 | $15.97M | $151.09M | $0.00 | $18.82M | $112000.00 | $2.91M | — | — | — |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-20.37M | $-21.64M | $-47.50M | $-36.52M | $-2.53M | $-44.80M | $-59.12M | $-81.55M | $-118.08M | $-127.20M | $-128.53M | $-93.03M | $-151.18M | $-50.88M | $-59.78M | $-70.51M | $-112.33M | $-141.43M | $-157.86M | $-258.80M |
| Net income growth (YoY) | — | -6.2% | -119.5% | +23.1% | +93.1% | -1668.6% | -32.0% | -37.9% | -44.8% | -7.7% | -1.0% | +27.6% | -62.5% | +66.3% | -17.5% | -18.0% | -59.3% | -25.9% | -11.6% | -63.9% |
| Profit margin | -413.2% | -424.0% | -637.1% | -240.6% | -5.4% | -483.5% | -527.8% | -1983.7% | -3292.8% | -2321.1% | -1894.0% | -730.1% | -1585.1% | -1424.0% | -805.9% | -1516.0% | -4765.6% | -2054.8% | -2248.8% | -17253.3% |